TY - JOUR
T1 - Thrombomodulin domains attenuate atherosclerosis by inhibiting thrombin-induced endothelial cell activation
AU - Wei, Hsi Ju
AU - Li, Yi Heng
AU - Shi, Guey Yueh
AU - Liu, Shu Lin
AU - Chang, Po Chiao
AU - Kuo, Cheng Hsiang
AU - Wu, Hua Lin
N1 - Funding Information:
This work was supported by National Science Council, Taiwan (Grants NSC 97-2752-B-006-003-PAE, NSC 97-2752-B-006-004-PAE, NSC 97-2752-B-006-005-PAE, and DOH100-TD-B-111-002).
PY - 2011/11/1
Y1 - 2011/11/1
N2 - AimsThrombin modulates the formation of atherosclerotic lesions by stimulating a variety of cellular effects through protease-activated receptor-1 (PAR-1) activation. Thrombomodulin (TM) inhibits thrombin effects by binding thrombin through its domains 2 and 3 (TMD23). We investigated whether recombinant TMD23 (rTMD23) could inhibit atherosclerosis via its thrombin-binding ability.Methods and resultsWild-type mouse rTMD23 and three mutants with altered thrombin-binding sites, rTMD23 (I425A), rTMD23 (D424A/D426A), and rTMD23 (D424A/I425A/D426A), were expressed and purified in the Pichia pastoris expression system. Wild-type rTMD23 and rTMD23 (D424A/D426A) could effectively bind thrombin, activate protein C, and prolong thrombin clotting time, whereas rTMD23 (I425A) and rTMD23 (D424A/I425A/D426A) lost these functions. Wild-type rTMD23, but not rTMD23 (I425A), decreased both the thrombin-induced surface PAR-1 internalization and the increase in cytoplasmic Ca 2 concentrations in endothelial cells (ECs). Wild-type rTMD23 and rTMD23 (D424A/D426A) also inhibited thrombin-induced adhesion molecules and monocyte chemoattractant protein-1 expression and increased permeability in ECs, whereas rTMD23 (I425A) and rTMD23 (D424A/I425A/D426A) had no such effects. Furthermore, wild-type rTMD23 and rTMD23 (D424A/D426A) were effective in reducing carotid ligation-induced neointima formation in C57BL/6 mice and atherosclerotic lesion formation in apolipoprotein E-deficient (ApoE-/-) mice, whereas rTMD23 with the I425A mutation showed impairment of this function. Wild-type rTMD23, but not rTMD23 (I425A), also markedly suppressed the PAR-1, the adhesion molecules expression, and the macrophage content in the carotid ligation model and ApoE-/-mice.ConclusionrTMD23 protein significantly reduces atherosclerosis and neointima formation through its thrombin-binding ability.
AB - AimsThrombin modulates the formation of atherosclerotic lesions by stimulating a variety of cellular effects through protease-activated receptor-1 (PAR-1) activation. Thrombomodulin (TM) inhibits thrombin effects by binding thrombin through its domains 2 and 3 (TMD23). We investigated whether recombinant TMD23 (rTMD23) could inhibit atherosclerosis via its thrombin-binding ability.Methods and resultsWild-type mouse rTMD23 and three mutants with altered thrombin-binding sites, rTMD23 (I425A), rTMD23 (D424A/D426A), and rTMD23 (D424A/I425A/D426A), were expressed and purified in the Pichia pastoris expression system. Wild-type rTMD23 and rTMD23 (D424A/D426A) could effectively bind thrombin, activate protein C, and prolong thrombin clotting time, whereas rTMD23 (I425A) and rTMD23 (D424A/I425A/D426A) lost these functions. Wild-type rTMD23, but not rTMD23 (I425A), decreased both the thrombin-induced surface PAR-1 internalization and the increase in cytoplasmic Ca 2 concentrations in endothelial cells (ECs). Wild-type rTMD23 and rTMD23 (D424A/D426A) also inhibited thrombin-induced adhesion molecules and monocyte chemoattractant protein-1 expression and increased permeability in ECs, whereas rTMD23 (I425A) and rTMD23 (D424A/I425A/D426A) had no such effects. Furthermore, wild-type rTMD23 and rTMD23 (D424A/D426A) were effective in reducing carotid ligation-induced neointima formation in C57BL/6 mice and atherosclerotic lesion formation in apolipoprotein E-deficient (ApoE-/-) mice, whereas rTMD23 with the I425A mutation showed impairment of this function. Wild-type rTMD23, but not rTMD23 (I425A), also markedly suppressed the PAR-1, the adhesion molecules expression, and the macrophage content in the carotid ligation model and ApoE-/-mice.ConclusionrTMD23 protein significantly reduces atherosclerosis and neointima formation through its thrombin-binding ability.
UR - http://www.scopus.com/inward/record.url?scp=80054108282&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80054108282&partnerID=8YFLogxK
U2 - 10.1093/cvr/cvr220
DO - 10.1093/cvr/cvr220
M3 - Article
C2 - 21840881
AN - SCOPUS:80054108282
SN - 0008-6363
VL - 92
SP - 317
EP - 327
JO - Cardiovascular Research
JF - Cardiovascular Research
IS - 2
ER -